ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 133 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,731,000 | -23.5% | 315,364 | +3.5% | 0.01% | -28.6% |
| Q1 2016 | $2,262,000 | -40.3% | 304,805 | -33.1% | 0.01% | -36.4% |
| Q4 2015 | $3,786,000 | -18.0% | 455,678 | -11.1% | 0.01% | -21.4% |
| Q3 2015 | $4,619,000 | -25.2% | 512,655 | -0.4% | 0.01% | -6.7% |
| Q2 2015 | $6,179,000 | +196.4% | 514,906 | +166.0% | 0.02% | +200.0% |
| Q1 2015 | $2,085,000 | – | 193,587 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |